ChemoMetec ASOCSE:CHEMM -1.46%99 Pretax Margin % is 48.78% as of Dec. 2025, which is 29% above its 10-year median of 37.78. GuruFocus rates OCSE:CHEMM with a GF Score™ of 99/100 and a GF Value™ of kr523.33 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, ChemoMetec AS ranks better than 98.16% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. ChemoMetec AS's Pre-Tax Income for the
six
months ended in Dec. 2025 was kr121.5 Mil. ChemoMetec AS's Revenue for the
six
months ended in Dec. 2025 was kr249.0 Mil. Therefore, ChemoMetec AS's pretax margin for the quarter that ended in Dec. 2025 was 48.78%.
The historical rank and industry rank for ChemoMetec AS's Pretax Margin % or its related term are showing as below:
OCSE:CHEMM'
s Pretax Margin % Range Over the Past 10 Years
Min: 9.58 Med: 37.78 Max: 51.84
Current: 46.37
OCSE:CHEMM's Pretax Margin % is ranked better than 98.16% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.4
vs OCSE:CHEMM: 46.37
ChemoMetec AS (OCSE:CHEMM) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
ChemoMetec AS Pretax Margin % Related Terms
ChemoMetec AS Pretax Margin % Historical Data
* Premium members only.
The historical data trend for ChemoMetec AS's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:CHEMM vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, ChemoMetec AS's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS (OCSE:CHEMM) has a Pretax Margin % of 48.78% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on ChemoMetec AS and its competitors. This is 29% above median its historical median of 37.78. Over the past decade, ChemoMetec AS's Pretax Margin % has ranged from 9.58 to 51.84. According to the industry distribution chart, ChemoMetec AS ranks #15 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 1.8%.
Is ChemoMetec AS's Pretax Margin % too high?
ChemoMetec AS's current Pretax Margin % of 48.78% is 29% above median its 10-year median of 37.78. Over the past 10 years, this metric has ranged from a low of 9.58 to a high of 51.84. The Medical Devices & Instruments industry median Pretax Margin % is 2.40. ChemoMetec AS's value of 48.78% is 1932.5% above this industry median. Based on the distribution chart, ChemoMetec AS ranks #15 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ChemoMetec AS ranks #15 out of 817 companies for Pretax Margin %. This places ChemoMetec AS in the top 2% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.40. ChemoMetec AS's value of 48.78% is 1932.5% above this benchmark. Historically, ChemoMetec AS's own Pretax Margin % has ranged from 9.58 to 51.84 over the past decade. While the company's 10-year median is 37.78 vs. the industry median of 2.40, ChemoMetec AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.40, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ChemoMetec AS's current Pretax Margin % of 48.78% is 1932.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on ChemoMetec AS and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ChemoMetec AS's current Pretax Margin % is 48.78%, which is 29% above median its own 10-year median of 37.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Significantly Undervalued. The stock's GF Value™ is kr523.33, compared to a current price of kr365.20 — trading 30.2% below its estimated fair value. The current Pretax Margin % is 48.78%, which is 29% above median its 10-year median of 37.78 and 1932.5% above the Medical Devices & Instruments industry median of 2.40. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current Pretax Margin % is 48.78% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?
Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued.
The current stock price of kr365.20 is trading 30.2% below its estimated GF Value™ of kr523.33.
GuruFocus considers ChemoMetec AS to be Significantly Undervalued.
Key valuation signals for OCSE:CHEMM:
Pretax Margin %: 48.78% (29% above median its 10-year median of 37.78)
GF Value™: kr523.33 vs. price of kr365.20 (30.2% below fair value)
Industry Position: 1932.5% above the Medical Devices & Instruments median (#15 of 817)
No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score
Get the complete analysis for OCSE:CHEMM
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:CHEMM has been successfully added to your 
